Skip to Main Content

Paper Details

Targeting Tropomyosin Receptor Kinase in Cutaneous CYLD Defective Tumors With Pegcantratinib: The TRAC Randomized Clinical Trial.
JAMA Dermatol
13
2018
Author NameAffiliation
Alan AshworthUniversity of California San Francisco Helen Diller Family Comprehensive Cancer Center
David J BurnInstitute of Genetic Medicine, Newcastle University
  • 1 - 2

Datasets

Release 1.2